Detalhe da pesquisa
1.
Responder rates with eptinezumab over 24 weeks in patients with prior preventive migraine treatment failures: post hoc analysis of the DELIVER randomized clinical trial.
Eur J Neurol
; 31(2): e16131, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-37955557
2.
Meta-analysis of placebo-arm dropouts in osteoporosis randomized-controlled trials and implications for nocebo-associated discontinuation of anti-osteoporotic drugs in clinical practice.
Osteoporos Int
; 34(3): 585-598, 2023 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-36596944
3.
The prevalence and burden of medication overuse headache in Greece.
Cephalalgia
; 43(6): 3331024231184909, 2023 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-37377005
4.
Real-world effectiveness of fremanezumab for the preventive treatment of migraine: Interim analysis of the pan-European, prospective, observational, phase 4 PEARL study.
Cephalalgia
; 43(11): 3331024231214987, 2023 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37987641
5.
Numbers needed to treat or harm and likelihood of being helped versus harmed for fremanezumab in patients who had prior inadequate response to two to four classes of migraine preventive medications: A post hoc analysis.
Headache
; 63(10): 1351-1358, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37955395
6.
Therapies targeting CGRP signaling for medication overuse headache.
Curr Opin Neurol
; 35(3): 353-359, 2022 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35674079
7.
Migraine: integrated approaches to clinical management and emerging treatments.
Lancet
; 397(10283): 1505-1518, 2021 04 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-33773612
8.
Visual snow: A systematic review and a case series.
Cephalalgia
; 42(13): 1409-1419, 2022 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-35945691
9.
Drug tolerability: How much ambiguity can be tolerated? A systematic review of the assessment of tolerability in clinical studies.
Br J Clin Pharmacol
; 88(2): 551-565, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34342031
10.
Understanding frontal lobe function in epilepsy: Juvenile myoclonic epilepsy vs. frontal lobe epilepsy.
Epilepsy Behav
; 134: 108850, 2022 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-35933958
11.
COVID-19 vaccine safety and nocebo-prone associated hesitancy in patients with systemic rheumatic diseases: a cross-sectional study.
Rheumatol Int
; 42(1): 31-39, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34739573
12.
Anti-CGRP monoclonal antibodies for migraine prevention: A systematic review and likelihood to help or harm analysis.
Cephalalgia
; 41(7): 851-864, 2021 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-33567891
13.
A population-based survey for disabling headaches in Greece: Prevalence, burden and treatment preferences.
Cephalalgia
; 41(7): 810-820, 2021 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-33525903
14.
Structured headache services as the solution to the ill-health burden of headache: 1. Rationale and description
J Headache Pain
; 22(1): 78, 2021 07 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-34289806
15.
Lateralization of Insular Ischemic Stroke is Not Associated With Any Stroke Clinical Outcomes: The Athens Stroke Registry.
J Stroke Cerebrovasc Dis
; 29(2): 104529, 2020 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-31806455
16.
European Headache Federation recommendations for placebo and nocebo terminology.
J Headache Pain
; 21(1): 117, 2020 Sep 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-32977761
17.
Trigeminal-Targeted Treatments in Migraine: Is 60% the Magic Number?
Headache
; 59(9): 1659-1661, 2019 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-31508812
18.
Consensus of the Hellenic Headache Society on the diagnosis and treatment of migraine.
J Headache Pain
; 20(1): 113, 2019 Dec 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-31835997
19.
Male and female sex hormones in primary headaches.
J Headache Pain
; 19(1): 117, 2018 Nov 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-30497379
20.
Calcitonin gene-related peptide monoclonal antibodies for migraine prevention: comparisons across randomized controlled studies.
Curr Opin Neurol
; 30(3): 272-280, 2017 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-28240610